Navigation Links
Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials
Date:5/7/2010

Leading Clinical Research Center Announces State-of-the-Art Overnight Facility

Garden City, NY (PRWEB) May 7, 2010 - Accumed Research Associates recently announced their continued growth by providing sleep study as well as overnight phase I and bioequivalence capabilities. Accumed, a leading clinical trials facility in Garden City, NY, now offers opportunities for all phases of clinical research with a well-equipped, state-of-the-art overnight facility for conducting clinical trials.

With more than nine years experience in all phases of clinical research studies, Dr. Mitchell Efros explained, “We wanted to become a complete research site and be able to deliver data in all aspects and phases of clinical trial research.” Dr Efros continued, “We expanded to include phase 1 and bioequivalence studies and are able to provide five associated physicians, two Nurse Practitioners as well as a Physician Assistant for our studies.”

Accumed has an extensive research database. Three research coordinators have more than16 years of combined research experience and support staff includes a data manager and regulatory specialist.

Many sponsors as well as contract research organizations (CRO’s) have utilized the expertise of Accumed and Dr. Efros for future direction and consultation. Accumed has over enrolled in more than 90% of recent trials conducted and has been the top enroller in a number of studies with enrollment performance status consistently at more than 95%.

Dr. Efros founded Accumed in 2001 and has successfully conducted more than 100 clinical trials. Accumed has become a well-known research center both in the local community and the industry due to its reputation for extensively trained employees who are dedicated to the highest standards of patient care. The site prepares for all monitoring visits and allots adequate time for the contract research associates (CRAs).

Dr. Efros and Accumed Research Associates are affiliated with the following prestigious research and medical organizations: Association of Clinical Research Professionals, Fellow of American College of Surgeons, American Urologic Association and American Association of Clinical Urologists.

Accumed Research Associates (http://www.AccumedResearch.com) is located in Garden City, NY on Long Island, and is a leader in clinical trials and studies. With more than nine years of experience in all phases of clinical research, Accumed Research Associates has access to a large research database and can prospectively identify suitable candidates for their clinical studies. The company’s strength includes its extensively trained employees dedicated to the highest standards of patient care as well as a state-of-the-art comprehensive facility, and research department.

# # #

Read the full story at http://www.prweb.com/releases/2010/05/prweb3945764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Accumed Research Associates Launches Official Website
2. New research identifies modifiable risk factors for heart disease
3. Nuvo Research announces early redemption of 5% convertible debentures
4. Researcher to track spread of disease, malware and power outages
5. UCSF Researchers Identify Regulator of Human Sperm Cells
6. Octapharma Accepting Applications for Research Grants Through March 31
7. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
8. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
9. University of Maryland chemist receives Astellas Award for blindness prevention research
10. Developing a cyberinfrastructure for comparative effectiveness in cancer research
11. Women should be allowed to eat, drink during labor: Queens University researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... Thinksport, the most award-winning sunscreen on ... of Marin. For the second year in a row, cyclists will stay protected ... are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which is ... in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) ... website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, SEO ... already in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
(Date:2/23/2017)... ... 23, 2017 , ... The Center for Autism and Related ... Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The ... see films in an environment that accommodates their unique needs. , Launched in ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... it will release fourth quarter and yearly financial ... 2017. AcelRx management will host an investment-community conference ... Pacific Time) on March 2 nd 2017 ...
(Date:2/23/2017)... ... has announced the addition of the "Global Antifungal Drugs Market Analysis ... The Global Antifungal Drugs Market is poised to grow ... approximately $12.8 billion by 2025. This industry report ... global as well as regional levels presented in the research scope. The ...
(Date:2/23/2017)... 2017 The top three players ... Healthcare, Koninklijke Philips N.V., and Schiller. Collectively, these companies ... market in 2015. Strong product portfolio and a monumental ... be aiding these players remain leaders in the fragmented ... in the global market are likely to focus on ...
Breaking Medicine Technology: